RAPT Therapeutics to be Added to the Russell 2000® and Russell Microcap® Indices

Ads

You May Also Like

OSE Immunotherapeutics Receives IDMC Approval to Continue “Atalante 1” Phase 3 NSCLC Clinical Trial of Tedopi®

Trial in Non-Small Cell Lung Cancer (NSCLC) Patients After Immune Checkpoint Inhibitor FailureCheckpoint Inhibitor ...

Molecular Diagnostics Market will be worth US$18.9 bn by 2025, Says TMR

Molecular Diagnostics Market: Rising Demand for Biomarkers for Rapid Diagnosis Sets Tone for GrowthAlbany, ...

Neovacs Issued New Broad Patent in China for IFNα Kinoid

PARIS, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Neovacs (Alternext Paris:ALNEV), a leader in active ...